UK’s AstraZeneca completes acquisition of SixPeaks Bio to advance next-gen obesity treatments
AstraZeneca finalises buyout of SixPeaks Bio to accelerate advanced obesity treatment pipeline. Get access to the full article? Become our ...
Sunday, January 25, 2026
Tag: BIO
Takeda Pharmaceutical Company (TAK) Signs a Research Partnership with Nabla Bio
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.